Scorpius Biomanufacturing

Activities: Manufacturing

Trending Articles

  1. GSK completes acquisition of 35Pharma, gaining pulmonary hypertension candidate The company has completed its purchase of the Canada-based biopharma for $950m, handing it a drug that is a potentially “best-in-class” therapy for blood pressure diseases...
  2. Amazon rolls out AI-powered platform Amazon Bio Discovery for drug discovery The new application will assist with drug design, allowing more researchers to access leading AI models rather than just those with AI and coding skills. Already in use with...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    From crisis response to operational resilience: rethinking recovery in pharmaceutical manufacturing (part I) Pharmaceutical crisis recovery has become a proactive operational capability by integrating risk management, culture, facility design and human factors to ensure resilience
  4. Lonza Nominates Stephen Fry as Independent Board Member Basel, Switzerland, 31 March 2026 – The Lonza Board of Directors today announced the nomination of Stephen Fry as an Independent Member of the Board. Subject to his election...
  5. Applied Biopharm Consulting awarded Innovation funding to validate AI-powered AAV vector engineering platform Irish biotech consultancy Applied Biopharm Consulting has secured an Innovation Voucher from the Local Enterprise Office Cork North & West to collaborate with an academic...

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

Related Content

Manufacturing

Process development and clinical manufacturing

Process development & cGMP contract manufacturing for biologics and cell therapies
Hi Tech Manufacturing

Mammalian biomanufacturing

Delivering consistent and scalable mammalian-derived products, Scorpius uses its American facilities to advance your drug from R&D to the clinic and beyond
Hi Tech Manufacturing

Microbial biomanufacturing

Scorpius’ team has extensive experience in E. coli microbial biomanufacturing, including hard-to-work-with inclusion bodies
Manufacturing

Scorpius appoints Gary Welch as Interim President

Gary will lead Scorpius through its next phase of growth
Subscribe now